Cochlear: FDA approves new Nucleus Profile Plus implant series with Android smartphone connectivity

CENTENNIAL -- Cochlear Limited ( ASX: COH), a global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration's approval of the new Cochlear Nucleus ... Read More

Monday June 17, 2019 0 comments Tags: Centennial, Cochlear Limited, Nucleus Profile Plus Implant, Tony Manna, Patricia Troutwein, FDA